Shares of Novavax NVAX lost nearly 20% on Wednesday after the company announced that the FDA has placed a clinical hold on ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...

GSK has reported positive interim results from its Phase II trial of mRNA-based multivalent influenza vaccine candidate, ...

There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna ... time that ...

The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...

With these results, the GSK mRNA seasonal influenza vaccine program will progress into late-stage clinical development. The trial studied a range of mRNA formulations in older and younger adults ...

More than 90 clinical trials are now underway to develop mRNA vaccines for a broad range of infectious diseases, such as cytomegalovirus (CMV), human immunodeficiency virus (HIV), influenza ...

Mater Researchers in Brisbane are leading a trial of a non-mRNA combined COVID-19 and flu vaccine that will protect people ...

A first-of-its-kind combined Covid-19 and influenza vaccine is being trialled by Queensland scientists in the hope it will ...

The most important thing to know is that the COVID vaccine is safe and effective, says Dr. Watkins. With that said, side effects from the COVID vaccine are rare, says Dr. Cennimo, and they usually ...